Pharmacology of 2-cyclohexylmethylidenehydrazinoadenosine (WRC-0470), a novel, short-acting adenosine A2A receptor agonist that produces selective coronary vasodilation
Authors:
- Pauline L. MartinPMPauline L. Martin
- Richard J. BarrettRBRichard J. Barrett
- Joel LindenJLJoel Linden
- William M. AbrahamWAWilliam M. Abraham
- 1 April 1997
- journal article
- Published by Wiley in Drug Development Research
- Vol. 40 (4) , 313-324
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Myocardial Contrast Echocardiography in Acute Myocardial Infarction Using Aortic Root Injections of Microbubbles in Conjunction With Harmonic Imaging: Potential Application in the Cardiac Catheterization LaboratoryJACC, 1997
- Pharmacological Stress Thallium Scintigraphy With 2-Cyclohexylmethylidenehydrazinoadenosine (WRC-0470)Circulation, 1996
- Selective Attenuation by N-0861 (N6-Endonorboran-2-yl-9-Methyladenine) of Cardiac A1Adenosine Receptor–Mediated Effects in HumansCirculation, 1996
- Adenosine A2b receptors evoke interleukin-8 secretion in human mast cells. An enprofylline-sensitive mechanism with implications for asthma.Journal of Clinical Investigation, 1995
- Hemodynamic Responses and Adverse Effects Associated With Adenosine and Dipyridamole Pharmacologic Stress Testing: A Comparison in 2,000 PatientsMayo Clinic Proceedings, 1995
- Safety profile of adenosine stress perfusion imaging: Results from the adenoscan multicenter trial registryJACC, 1994
- Adenosine-induced bronchoconstriction and its inhibition by nedocromil sodiumJournal of Allergy and Clinical Immunology, 1993
- Adenosine system in the heartDrug Development Research, 1993
- Tolerance and safety of pharmacologic coronary vasodilation with adenosine in association with thallium-201 scintigraphy in patients with suspected coronary artery diseaseJACC, 1991
- Dipyridamole thallium 201 imaging. How safe is it?Circulation, 1990